ftInvstr
SIGACHI · Healthcare ₹27.2 -1.81% Mkt Cap ₹1040 Cr

SIGACHI

Healthcare Drug Manufacturers - Specialty & Generic
₹27.2
-1.81% today · 30d -4.39%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SIGACHI. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹122 Cr
-4.92% YoY
NET PROFIT
₹8 Cr
-52.71% YoY
OPM
14.41%
-9.17pp YoY
EPS
₹0.2
PE 42.43
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-3.5% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SIGACHI42.4316.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
48
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation FAIR 40
Growth MUTED 30
Profitability DECENT 68
Technicals NEUTRAL 62
Risk LOW 70
Key Stats
TTM PE
42.43
P/B
1.93
52W HIGH
₹40.8
OFF HIGH
-33.33%
DIV YIELD
0.0%
MKT CAP
₹1040 Cr
◉ Active Signals
MACDNeutral0.2736
RSI(14)Neutral46.86
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SIGACHI and at what entry.

Sign up freeSign in